Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
BioMarin, 06/10/09

BioMarin Pharmaceutical Inc. announced results from the Phase 1 clinical study of PEG-PAL for the treatment of phenylketonuria. The company expects to initiate the Phase 2 clinical study in late June or early July, pending institutional review board approval from the clinical trial sites. The U.S. Food and Drug Administration has reviewed the Phase II clinical trial protocol.


Today in Drug Trials...keeping you current

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

See All of Drug Trials

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address